This post is from a suggested group
Spirometer Market: Rising Demand for Portable and Digital Spirometry in Chronic Respiratory Disease Management
The Spirometer Market is undergoing a transformative phase, primarily fueled by the escalating global prevalence of Chronic Obstructive Pulmonary Disease (COPD) and asthma, alongside other respiratory conditions. Spirometry, which measures lung function, is a fundamental tool for the diagnosis and ongoing management of these chronic diseases. A major trend is the shift toward portable, handheld, and digital spirometers, which offer enhanced convenience for both healthcare providers and patients. These modern devices often integrate wireless connectivity, allowing for real-time data transfer to electronic health records (EHRs) and facilitating tele-health and remote patient monitoring (RPM). This digital evolution is crucial for early detection and for enabling patients to track their lung health at home, leading to better adherence to treatment plans and prompt intervention during exacerbations, a critical factor in managing conditions like COPD.